Menu Close

Category: MAGL

The data ought to be interpreted in light from the highly chosen patient population in clinical trials of anti-PD-1 antibodies as these patients may have different baseline characteristics weighed against those contained in the retrospective analysis of ipilimumab sequencing, therefore, potential sequencing trials will be definitively necessary to answer this question

The data ought to be interpreted in light from the highly chosen patient population in clinical trials of anti-PD-1 antibodies as these patients may have…